Analysts at RBC Capital Markets Have Reiterated their Past ‘Outperform’ rating on Shares Spirax-Sarco Engineering (LON:SPX), Set a GBX 3300 Target

Share

Spirax-Sarco Engineering (LON:SPX) Rating Reaffirmed

They currently have a GBX 3300 TP on Spirax-Sarco Engineering (LON:SPX). The target price by RBC Capital Markets would suggest a potential upside of 8.91% from the company’s last stock price. This has been disclosed in a very recent research note on Tuesday morning.

From a total of 13 analysts covering Spirax-Sarco Engineering PLC (LON:SPX) stock, 5 rate it a ”Buy”, 0 a “Sell”, and 9 a ”Hold”. This means that 36% of the ratings are positive. The highest target price is GBX 3650 while the lowest target price is GBX 2950. The mean of all analyst targets is GBX 3170 with a 1.71% above today’s (GBX 3032) stock price. Spirax-Sarco Engineering PLC was the topic of 40 analyst reports since August 5, 2015 according to the firm StockzIntelligence Inc. RBC Capital Markets maintained shares on December 8 with “Outperform” rating. Morgan Stanley maintained shares with “Equalwt/In-Line” rating and GBX 2950 target share price in a report from a November 17. Credit Suisse maintained SPX stock in a recent report from November 25 with “Outperform” rating. Liberum Capital maintained the rating on October 16. Liberum Capital has a “Hold” rating and a GBX 3140 price target on shares. Finally, BNP Paribas maintained the stock with “Neutral” rating in a report issued on a November 18.

Approximately 2,264 shares of stock traded hands. Spirax-Sarco Engineering plc (LON:SPX) has declined 15.06% since May 18, 2015 and is downtrending. It has underperformed by 11.38% the S&P500.

Analysts at RBC Capital Markets Have Reiterated their Past ‘Outperform’ rating on Shares Spirax-Sarco Engineering (LON:SPX), Set a GBX 3300 Target

Spirax-Sarco Engineering plc is a United Kingdom industrial engineering company, which is engaged in steam system specialties and peristaltic pumps, and associated fluid path technologies. The company has a market cap of 2.22 billion GBP. The Company’s two businesses are Spirax Sarco for steam specialties, and Watson-Marlow for peristaltic pumps and associated fluid path technologies. It has 23.28 P/E ratio. Spirax Sarco’s steam specialties supplies engineered solutions for the design, maintenance and provision of industrial and commercial steam systems.

COMMENTS: